RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma—year-5 toxicity and cosmesis

Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

Timothy J. Whelan, Jean‐Philippe Pignol, Mark N. Levine et al. · New England Journal of Medicine · 2010 · 1.9K citations · Full text

Medicine, Oncology, Radiation Oncology +16

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

Jayant S. Vaidya, David Joseph, Jeffrey Tobias et al. · The Lancet · 2010 · 763 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Accelerated partial breast irradiation: An analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy

David E. Wazer, Seth Kaufman, Laurie W. Cuttino et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 196 citations

Medicine, Oncology, Radiation Oncology +17

Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study

Csaba Polgár, Tibor Major, János Fodor et al. · Radiotherapy and Oncology · 2010 · 191 citations

Medicine, Oncology, Radiation Oncology +13

A Phase II Trial of Brachytherapy Alone After Lumpectomy for Select Breast Cancer: Tumor Control and Survival Outcomes of RTOG 95-17

Douglas W. Arthur, Kathryn Winter, Robert R. Kuske et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 179 citations · Full text

Medicine, Oncology, Surgery +16